ROYAL BANK OF CANADA - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 124 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$32,000
-8.6%
13,602
+83.5%
0.00%
Q2 2023$35,000
+52.2%
7,411
+78.8%
0.00%
Q1 2023$23,000
-65.2%
4,144
-64.9%
0.00%
Q4 2022$66,000
+500.0%
11,809
+630.3%
0.00%
Q3 2022$11,000
-83.1%
1,617
-91.5%
0.00%
Q2 2022$65,000
-59.9%
18,977
-17.2%
0.00%
Q1 2022$162,000
-42.1%
22,916
-31.9%
0.00%
Q4 2021$280,000
+582.9%
33,636
+466.2%
0.00%
Q3 2021$41,000
-64.0%
5,941
+24.7%
0.00%
Q2 2021$114,000
+119.2%
4,765
+90.3%
0.00%
Q1 2021$52,000
-68.5%
2,504
-62.8%
0.00%
Q4 2020$165,000
-55.4%
6,739
-48.3%
0.00%
Q3 2020$370,000
+496.8%
13,042
+0.8%
0.00%
Q2 2020$62,000
+67.6%
12,940
+23.9%
0.00%
Q1 2020$37,000
+236.4%
10,445
+227.2%
0.00%
Q4 2019$11,000
+450.0%
3,192
+432.0%
0.00%
Q3 2019$2,0000.0%6000.0%0.00%
Q2 2019$2,000
-50.0%
6000.0%0.00%
Q1 2019$4,000
+33.3%
6000.0%0.00%
Q4 2018$3,000
-62.5%
600
-45.6%
0.00%
Q3 2018$8,000
+14.3%
1,103
+32.7%
0.00%
Q2 2018$7,000
+40.0%
831
+17.5%
0.00%
Q1 2018$5,000
-37.5%
707
-12.5%
0.00%
Q4 2017$8,000
-81.4%
808
-70.3%
0.00%
Q3 2017$43,000
+330.0%
2,716
+193.0%
0.00%
Q2 2017$10,000
-28.6%
927
-27.3%
0.00%
Q1 2017$14,000
+100.0%
1,275
+92.6%
0.00%
Q4 2016$7,000
+75.0%
662
+120.7%
0.00%
Q3 2016$4,000
+300.0%
300
+1664.7%
0.00%
Q4 2015$1,000
-88.9%
17
-94.3%
0.00%
Q3 2015$9,0003000.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$55,018,5673.99%
Lion Point Capital, LP 691,803$1,646,4910.73%
Eversept Partners, LP 2,352,556$5,599,0830.47%
Soleus Capital Management, L.P. 1,820,983$4,333,9400.40%
Simplify Asset Management Inc. 550,626$1,310,4900.15%
Avoro Capital Advisors LLC 2,500,000$5,950,0000.09%
IRONWOOD INVESTMENT MANAGEMENT LLC 45,419$108,0970.07%
Knott David M Jr 70,000$1670.06%
XTX Topco Ltd 150,097$357,2310.06%
FEDERATED HERMES, INC. 8,981,717$21,376,4860.06%
View complete list of SERES THERAPEUTICS INC shareholders